Literature DB >> 22210062

Catechol-O-methyltransferase genotype predicts pain severity in hospitalized burn patients.

Danielle C Orrey1, Andrey V Bortsov, Janelle M Hoskins, Jeffrey W Shupp, Samuel W Jones, Bryan J Cicuto, James Hwang, Marion H Jordan, James H Holmes, Linwood R Haith, Brandon M Roane, Luda Diatchenko, Bruce A Cairns, Samuel A McLean.   

Abstract

Increasing evidence suggests that stress system activation after burn injury may contribute to burn-related pain. If this is the case, then genetic variations influencing the function of important stress system components, such as the enzyme catechol-O-methyltransferase (COMT), may predict pain severity after thermal burn injury. The authors evaluated the association between COMT genotype and pain intensity in 57 individuals hospitalized after thermal burn injury. Consenting participants at four burn centers were genotyped and completed daily 0 to 10 numeric rating scale pain assessments on 2 consecutive days including evaluation of waking, least, and worst pain. The association between COMT genotype and individual pain outcomes was calculated using a linear mixed model adjusting for sociodemographic and burn injury characteristics. Overall pain (combination of least, worst, and waking pain scores) was significantly higher in patients with a COMT pain vulnerable genotype (6.3 [0.4] vs 5.4 [0.4], P = .037). Individuals with a COMT pain vulnerable genotype also had significantly higher "least pain" scores (3.8 [0.5] vs 2.6 [0.4], P = .017) and significantly higher pain on awakening (6.8 [0.5] vs 5.3 [0.4], P = .004). Differences in worst pain according to genotype group were not significant. COMT pain vulnerable genotype was a stronger predictor of overall pain severity than burn size, burn depth, or time from admission to pain interview assessment. These findings suggest that genetic factors influencing stress system function may have an important influence on pain severity after burn injury. Further studies of genetic predictors of pain after burn injury are needed.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22210062      PMCID: PMC3319634          DOI: 10.1097/BCR.0b013e31823746ed

Source DB:  PubMed          Journal:  J Burn Care Res        ISSN: 1559-047X            Impact factor:   1.845


  21 in total

1.  Clinical response to regional intravenous guanethidine in patients with rheumatoid arthritis.

Authors:  J D Levine; K Fye; P Heller; A I Basbaum; Q Whiting-O'Keefe
Journal:  J Rheumatol       Date:  1986-12       Impact factor: 4.666

Review 2.  Catechol-O-methyltransferase (COMT): biochemistry, molecular biology, pharmacology, and clinical efficacy of the new selective COMT inhibitors.

Authors:  P T Männistö; S Kaakkola
Journal:  Pharmacol Rev       Date:  1999-12       Impact factor: 25.468

3.  Propranolol and the treatment of rheumatoid arthritis.

Authors:  R Kaplan; C A Robinson; J F Scavulli; J H Vaughan
Journal:  Arthritis Rheum       Date:  1980-02

4.  The pain of burns: characteristics and correlates.

Authors:  M Choinière; R Melzack; J Rondeau; N Girard; M J Paquin
Journal:  J Trauma       Date:  1989-11

Review 5.  Burn injury pain: the continuing challenge.

Authors:  Gretchen J Summer; Kathleen A Puntillo; Christine Miaskowski; Paul G Green; Jon D Levine
Journal:  J Pain       Date:  2007-04-16       Impact factor: 5.820

6.  Impaired sympathetic influence on the immune response in patients with rheumatoid arthritis due to lymphocyte subset-specific modulation of beta 2-adrenergic receptors.

Authors:  C G Baerwald; M Laufenberg; T Specht; P von Wichert; G R Burmester; A Krause
Journal:  Br J Rheumatol       Date:  1997-12

7.  Genetic basis for individual variations in pain perception and the development of a chronic pain condition.

Authors:  Luda Diatchenko; Gary D Slade; Andrea G Nackley; Konakporn Bhalang; Asgeir Sigurdsson; Inna Belfer; David Goldman; Ke Xu; Svetlana A Shabalina; Dmitry Shagin; Mitchell B Max; Sergei S Makarov; William Maixner
Journal:  Hum Mol Genet       Date:  2004-11-10       Impact factor: 6.150

Review 8.  The management of pain in the burns unit.

Authors:  P Richardson; L Mustard
Journal:  Burns       Date:  2009-06-07       Impact factor: 2.744

9.  Haplotype associations with quantitative traits in the presence of complex multilocus and heterogeneous effects.

Authors:  Kyoko Shibata; Luda Diatchenko; Dmitri V Zaykin
Journal:  Genet Epidemiol       Date:  2009-01       Impact factor: 2.135

10.  Responses to Drs. Kim and Dionne regarding comments on Diatchenko, et al. Catechol-O-methyltransferase gene polymorphisms are associated with multiple pain-evoking stimuli. Pain 2006; 125: 216-24.

Authors:  Luda Diatchenko; Andrea G Nackley; Gary D Slade; Inna Belfer; Mitchell B Max; David Goldman; William Maixner
Journal:  Pain       Date:  2007-06       Impact factor: 7.926

View more
  9 in total

1.  Common variants of catechol-O-methyltransferase influence patient-controlled analgesia usage and postoperative pain in patients undergoing total hysterectomy.

Authors:  E-C Tan; E C P Lim; C E Ocampo; J C Allen; B-L Sng; A T Sia
Journal:  Pharmacogenomics J       Date:  2015-05-12       Impact factor: 3.550

Review 2.  Neuropathic ocular pain: an important yet underevaluated feature of dry eye.

Authors:  A Galor; R C Levitt; E R Felix; E R Martin; C D Sarantopoulos
Journal:  Eye (Lond)       Date:  2014-11-07       Impact factor: 3.775

Review 3.  Alternative Splicing of G Protein-Coupled Receptors: Relevance to Pain Management.

Authors:  Folabomi A Oladosu; William Maixner; Andrea G Nackley
Journal:  Mayo Clin Proc       Date:  2015-08       Impact factor: 7.616

4.  Somatic symptoms among US adolescent females: associations with sexual and physical violence exposure.

Authors:  Carolyn Tucker Halpern; Christine M Tucker; Angela Bengtson; Lawrence L Kupper; Samuel A McLean; Sandra L Martin
Journal:  Matern Child Health J       Date:  2013-12

5.  Results of a pilot multicenter genotype-based randomized placebo-controlled trial of propranolol to reduce pain after major thermal burn injury.

Authors:  Danielle C Orrey; Omar I Halawa; Andrey V Bortsov; Jeffrey W Shupp; Samuel W Jones; Linwood R Haith; Janelle M Hoskins; Marion H Jordan; Shrikant I Bangdiwala; Brandon R Roane; Timothy F Platts-Mills; James H Holmes; James Hwang; Bruce A Cairns; Samuel A McLean
Journal:  Clin J Pain       Date:  2015-01       Impact factor: 3.442

6.  Acute severe pain is a common consequence of sexual assault.

Authors:  Samuel A McLean; April C Soward; Lauren E Ballina; Catherine Rossi; Suzanne Rotolo; Rebecca Wheeler; Kelly A Foley; Jayne Batts; Terry Casto; Renee Collette; Debra Holbrook; Elizabeth Goodman; Sheila A M Rauch; Israel Liberzon
Journal:  J Pain       Date:  2012-06-13       Impact factor: 5.820

7.  Genotypes of Pain and Analgesia in a Randomized Trial of Irritable Bowel Syndrome.

Authors:  Jan Vollert; Ruisheng Wang; Stephanie Regis; Hailey Yetman; Anthony J Lembo; Ted J Kaptchuk; Vivian Cheng; Judy Nee; Johanna Iturrino; Joseph Loscalzo; Kathryn T Hall; Jocelyn A Silvester
Journal:  Front Psychiatry       Date:  2022-03-23       Impact factor: 5.435

8.  Modification of COMT-dependent pain sensitivity by psychological stress and sex.

Authors:  Carolina B Meloto; Andrey V Bortsov; Eric Bair; Erika Helgeson; Cara Ostrom; Shad B Smith; Ronald Dubner; Gary D Slade; Roger B Fillingim; Joel D Greenspan; Richard Ohrbach; William Maixner; Samuel A McLean; Luda Diatchenko
Journal:  Pain       Date:  2016-04       Impact factor: 7.926

9.  Protocol for the first large-scale emergency care-based longitudinal cohort study of recovery after sexual assault: the Women's Health Study.

Authors:  Nicole A Short; Jenyth Sullivan; April Soward; Kenneth A Bollen; Israel Liberzon; Sandra Martin; Sheila A M Rauch; Kathy Bell; Catherine Rossi; Megan Lechner; Carissa Novak; Kristen Witkemper; Ronald C Kessler; Samuel A McLean
Journal:  BMJ Open       Date:  2019-11-21       Impact factor: 2.692

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.